Dianthus Therapeutics to Participate in Three Healthcare Investor Conferences in September
Ulta Beauty Reports Downbeat Results, Joins Elastic And Other Big Stocks Moving Lower In Friday's Pre-Market Session
J&J Submits FDA Application for Myasthenia Gravis Drug Nipocalimab
Analysts Offer Insights on Healthcare Companies: Xenon (XENE), Nuvalent (NUVL) and Dianthus Therapeutics (DNTH)
HC Wainwright & Co. Reiterates Buy on Dianthus Therapeutics, Maintains $40 Price Target
Promising Clinical Developments Bolster Buy Rating for Dianthus Therapeutics